- Home
- CAPT vs BRNS Comparison
CAPT vs BRNS Comparison
Compare CAPT & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- BRNS
- Stock Information
- Founded
- CAPT 2005
- BRNS 2016
- Country
- CAPT South Korea
- BRNS United Kingdom
- Employees
- CAPT N/A
- BRNS N/A
- Industry
- CAPT Blank Checks
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- CAPT Finance
- BRNS Health Care
- Exchange
- CAPT Nasdaq
- BRNS Nasdaq
- Market Cap
- CAPT 41.9M
- BRNS 36.7M
- IPO Year
- CAPT N/A
- BRNS 2021
- Fundamental
- Price
- CAPT $0.68
- BRNS $1.14
- Analyst Decision
- CAPT
- BRNS Strong Buy
- Analyst Count
- CAPT 0
- BRNS 2
- Target Price
- CAPT N/A
- BRNS $4.00
- AVG Volume (30 Days)
- CAPT 334.4K
- BRNS 69.8K
- Earning Date
- CAPT 01-01-0001
- BRNS 11-06-2024
- Dividend Yield
- CAPT N/A
- BRNS N/A
- EPS Growth
- CAPT N/A
- BRNS N/A
- EPS
- CAPT N/A
- BRNS N/A
- Revenue
- CAPT $17,389,944.00
- BRNS $14,969,000.00
- Revenue This Year
- CAPT N/A
- BRNS $1,805.74
- Revenue Next Year
- CAPT N/A
- BRNS N/A
- P/E Ratio
- CAPT N/A
- BRNS N/A
- Revenue Growth
- CAPT 84.70
- BRNS 106.21
- 52 Week Low
- CAPT $0.65
- BRNS $0.80
- 52 Week High
- CAPT $7.92
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- CAPT 36.38
- BRNS 57.61
- Support Level
- CAPT $0.65
- BRNS $0.80
- Resistance Level
- CAPT $0.99
- BRNS $1.05
- Average True Range (ATR)
- CAPT 0.11
- BRNS 0.12
- MACD
- CAPT 0.01
- BRNS 0.03
- Stochastic Oscillator
- CAPT 8.70
- BRNS 100.00
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.